Joel Greenblatt acquired 11.5 Thousand Veracyte shares worth $250 Thousand. That's 0.00% of their equity portfolio (1165th largest holding). The first Veracyte trade was made in Q2 2019. Since then Joel Greenblatt bought shares five more times and sold shares on seven occasions. The investor's estimated purchase price is $265 Thousand, resulting in a loss of 5.4%.